Repare Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 34.94 million compared to USD 34.76 million a year ago. Basic loss per share from continuing operations was USD 0.83 compared to USD 0.83 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.865 USD | -3.37% | +9.92% | -46.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.85% | 170M | |
+48.85% | 56.95B | |
+39.98% | 40.26B | |
-7.13% | 39.32B | |
-4.42% | 28.37B | |
+12.33% | 26.45B | |
-18.07% | 19.41B | |
+29.54% | 12.54B | |
+26.07% | 12.21B | |
-0.71% | 12.15B |
- Stock Market
- Equities
- RPTX Stock
- News Repare Therapeutics Inc.
- Repare Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023